Completed
A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)
NCT00430495
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
- Locations
-
- EMD Serono Rockland, Massachusetts, United States
- Merck/Serono Canada